미국의 원격의료 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 제공 모드별, 최종 용도별, 질병 영역별, 부문별 예측(2025-2030년)

U.S. Telehealth Market Growth & Trends:

The U.S. telehealth market size is expected to reach USD 150.13 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to grow at a CAGR of 23.8% from 2025 to 2030. Several key factors are contributing to the growth of the telehealth industry in the U.S. These include the increasing adoption of digital health services, a favorable consumer base, and significant investment. Furthermore, the growing demand for remote patient monitoring and advancements in digital communication technology that enhances healthcare services are anticipated to fuel market growth in the coming years. The shortage of physicians and clinicians in the U.S. is also expected to be a driving force behind the telehealth industry's expansion.

For instance, a report released by the Association of American Medical Colleges in June 2021 projects a potential deficit of 37,800 to 124,000 physicians by 2034, encompassing both specialty and primary care. Furthermore, the market growth has been propelled by the increased utilization of digital healthcare platforms for remote patient visits, driven by the implementation of social distancing measures during the COVID-19 pandemic in the U.S. This shift has significantly contributed to the expansion of the market. For example, the Centers for Disease Control and Prevention (CDC) reported a substantial 154% increase in telehealth visits in the U.S. during March 2020 compared to the previous year, specifically in March 2019.

These remote digital healthcare services have proven beneficial by reducing disease exposure risks for both patients and healthcare staff. In addition,the growing accessibility of the Internet among the U.S. population and the rising adoption of devices, such as computers, tablets, and smartphones, create potential opportunities for industry growth.Telehealth offers potential cost savings for both patients and healthcare systems. By reducing the need for in-person visits and associated expenses, such as travel costs and facility fees, telehealth can lower overall healthcare expenditures. For instance, according to a January 2022 report by Cigna, virtual care was associated with an approximate cost reduction of $100 per visit in healthcare expenses.

Similarly, a recent publication in JAMA Network Open revealed that telehealth services played a significant role in reducing time and travel expenses for non-elderly individuals with cancer. The study reported cost savings ranging from USD 147.4 to USD 186.1 as a result of utilizing telehealth.Moreover, telehealth can increase efficiency by reducing wait times, optimizing appointment scheduling, and streamlining administrative processes. Furthermore,there is an increasing demand for remote patient monitoring services in the U.S., which enable real-time interactions between patients and physicians. These services have become more intelligent and cost-effective, leading to improved clinical outcomes.

As a result, telehealth providers are inclined to invest more in this market. To keep pace with this healthcare revolution, healthcare organizations in the U.S. are actively transforming their infrastructure. They are rapidly upgrading themselves with six crucial components: IT infrastructures, hardware, software, Internet of Things (IoT) capabilities, scalable design, data management, and patient security. For example, in June 2021, Persistent Systems partnered with and invested in IBM to enhance its digital transformation, modernize core IT facilities, and optimize its hybrid cloud platform for customers.

U.S. Telehealth Market Report Highlights:

• The services segment held the largest revenue share of 47.4% in 2024. The growing demand for telehealth applications in chronic disease management, real-time monitoring, and the continuous advancements in digital infrastructure, internet accessibility, and smartphone usage contribute to this segment's growth.
• The web-based segment held the largest revenue share of 45.9% in 2024. The segment's growth is fueled by the rising use of web-based delivery methods in mobile health communication and remote patient monitoring, which aim to enhance the quality of healthcare in rural regions.
• The psychiatry segment dominated the market with a revenue share of 12.4% in 2024 and is anticipated to grow at the fastest rate over the forecast period.
• The providers segment dominated the market with a revenue share of 52.6% in 2024. The growth is attributed to the growing adoption of telehealth, teleconsultation, and telemedicine among healthcare professionals to reduce the burden on healthcare facilities.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Delivery Mode outlook
  • 2.2.3. Disease Area outlook
  • 2.2.4. End Use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Telehealth Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Telehealth: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Telehealth Market Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. U.S. Telehealth Market, by Product, 2018 to 2030
• 4.5. Hardware
  • 4.5.1. Hardware market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Monitors
    • 4.5.2.1. Monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Medical Peripheral Devices
    • 4.5.3.1. Medical Peripheral Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3.2. Blood Pressure Meters
      • 4.5.3.2.1. Blood Pressure Meters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3.3. Blood Glucose Meters
      • 4.5.3.3.1. Blood Glucose Meters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3.4. Weighing Scales
      • 4.5.3.4.1. Weighing Scales market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3.5. Pulse Oximeters
      • 4.5.3.5.1. Pulse Oximeters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3.6. Peak Flow Meters
      • 4.5.3.6.1. Peak Flow Meters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3.7. ECG Monitors
      • 4.5.3.7.1. ECG Monitors market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3.8. Others
      • 4.5.3.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.6. Software
  • 4.6.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.2. Standalone Software
    • 4.6.2.1. Standalone Software market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6.3. Integrated Software
    • 4.6.3.1. Integrated Software market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.7. Services
  • 4.7.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7.2. Remote Patient Monitoring
    • 4.7.2.1. Remote Patient Monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7.3. Real-Time Interactions
    • 4.7.3.1. Real-Time Interactions market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7.4. Store And Forward
    • 4.7.4.1. Store And Forward market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7.5. Other Services
    • 4.7.5.1. Other Services market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Telehealth Market Segment Analysis, By Delivery Mode, 2018 - 2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. Delivery Mode Market Share Analysis, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. U.S. Telehealth Market, by Delivery Mode, 2018 to 2030
• 5.5. On-Premises
  • 5.5.1. On-Premises market estimates and forecasts, 2018 to 2030 (USD million)
• 5.6. Web-Based
  • 5.6.1. Web-Based market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.7. Cloud-Based
  • 5.7.1. Cloud-Based market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. U.S. Telehealth Market Segment Analysis, By Disease Area, 2018 - 2030 (USD Million)

• 6.1. Definition and Scope
• 6.2. Disease Area Market Share Analysis, 2024 & 2030
• 6.3. Segment Dashboard
• 6.4. U.S. Telehealth Market, by Disease Area, 2018 to 2030
• 6.5. Psychiatry
  • 6.5.1. Psychiatry market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Substance Use
  • 6.6.1. Substance Use market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Radiology
  • 6.7.1. Radiology market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.8. Endocrinology
  • 6.8.1. Endocrinology market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.9. Gastroenterology
  • 6.9.1. Gastroenterology market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.10. Dermatology
  • 6.10.1. Dermatology market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.11. Neurological Medicine
  • 6.11.1. Neurological Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.12. ENT
  • 6.12.1. ENT market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.13. Cardiology
  • 6.13.1. Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.14. Oncology
  • 6.14.1. Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.15. Dental
  • 6.15.1. Dental market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.16. Gynecology
  • 6.16.1. Gynecology market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.17. General Medicine
  • 6.17.1. General Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.18. Others
  • 6.18.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Telehealth Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 7.1. Definition and Scope
• 7.2. End Use Market Share Analysis, 2024 & 2030
• 7.3. Segment Dashboard
• 7.4. U.S. Telehealth Market, by End Use, 2018 to 2030
• 7.5. Payers
  • 7.5.1. Payers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Providers
  • 7.6.1. Providers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Patients
  • 7.7.1. Patients market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Profiles
  • 8.3.1. Koninklijke Philips N.V.
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. GE Healthcare
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Oracle (Cerner Corporation)
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Siemens Healthineers
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Medtronic
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Teladoc Health Inc
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. American Well
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. MDLIVE
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Doctor on Demand
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. GlobalMed
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives